Read More Healthcare Industry News BCAL Diagnostics (ASX: BDX) shares rise after ClearNote deal — is this the turning point investors were waiting for? BCAL Diagnostics (ASX: BDX) expands with ClearNote Health deal for ovarian and pancreatic cancer tests—can this pivot revive its struggling stock? byPallavi MadhirajuSeptember 18, 2025